In the last trading session, 0.29 million IO Biotech Inc (NASDAQ:IOBT) shares changed hands as the company’s beta touched 0.26. With the company’s per share price at $0.91 changed hands at $0.02 or 2.29% during last session, the market valuation stood at $60.94M. IOBT’s last price was a discount, traded about -130.77% off its 52-week high of $2.10. The share price had its 52-week low at $0.66, which suggests the last value was 27.47% up since then. When we look at IO Biotech Inc’s average trading volume, we note the 10-day average is 0.31 million shares, with the 3-month average coming to 350.81K.
Analysts gave the IO Biotech Inc (IOBT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.67. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended IOBT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. IO Biotech Inc’s EPS for the current quarter is expected to be -0.4.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IO Biotech Inc (NASDAQ:IOBT) trade information
Instantly IOBT was in green as seen at the end of in last trading. With action 21.84%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -50.80%, with the 5-day performance at 21.84% in the green. However, in the 30-day time frame, IO Biotech Inc (NASDAQ:IOBT) is 30.67% up. Looking at the short shares, we see there were 0.2 million shares sold at short interest cover period of 1.89 days.
IO Biotech Inc (IOBT) estimates and forecasts
Data shows that the IO Biotech Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -21.61% over the past 6 months, a 31.82% in annual growth rate that is considerably higher than the industry average of 16.70%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -46.06%. The 2024 estimates are for IO Biotech Inc earnings to increase by 31.62%.
IOBT Dividends
IO Biotech Inc is expected to release its next quarterly earnings report in January.
IO Biotech Inc (NASDAQ:IOBT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.24% of IO Biotech Inc shares while 76.79% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 76.97%. There are 76.79% institutions holding the IO Biotech Inc stock share, with VIVO CAPITAL, LLC the top institutional holder. As of 2024-06-30, the company held 9.3706% of the shares, roughly 6.17 million IOBT shares worth $7.22 million.
NOVO HOLDINGS A/S holds the second largest percentage of outstanding shares, with 6.7234% or 4.43 million shares worth $5.18 million as of 2024-06-30.
